DACARBAZINE

Generic: DACARBAZINE

Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
DACARBAZINEActive Substance
1999-08-27Original Approval

DACARBAZINE is FDA application ANDA075371, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FEBRILE NEUTROPENIA
652 reports
2
OFF LABEL USE
621 reports
3
NEUTROPENIA
524 reports
4
PYREXIA
394 reports
5
DRUG INEFFECTIVE
342 reports
6
DISEASE PROGRESSION
318 reports
7
NEUROPATHY PERIPHERAL
308 reports
8
NAUSEA
288 reports
9
ANAEMIA
262 reports
10
VOMITING
247 reports